Growth Metrics

HCA Healthcare (HCA) Gains from Investment Securities (2016 - 2026)

HCA Healthcare (HCA) has disclosed Gains from Investment Securities for 17 consecutive years, with -$103.0 million as the latest value for Q1 2026.

  • For Q1 2026, Gains from Investment Securities fell 1130.0% year-over-year to -$103.0 million; the TTM value through Mar 2026 reached -$185.0 million, down 109.97%, while the annual FY2025 figure was $4.1 million, 3965.35% up from the prior year.
  • Gains from Investment Securities hit -$103.0 million in Q1 2026 for HCA Healthcare, up from -$299.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $2.0 billion in Q4 2024 and bottomed at -$299.0 million in Q4 2025.
  • Average Gains from Investment Securities over 5 years is $106.0 million, with a median of -$2.0 million recorded in 2024.
  • Year-over-year, Gains from Investment Securities soared 2427.27% in 2023 and then plummeted 1130.0% in 2026.
  • HCA Healthcare's Gains from Investment Securities stood at $11.0 million in 2022, then skyrocketed by 2427.27% to $278.0 million in 2023, then soared by 630.58% to $2.0 billion in 2024, then tumbled by 114.72% to -$299.0 million in 2025, then soared by 65.55% to -$103.0 million in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$103.0 million, -$299.0 million, and $328.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.